Derived neutrophil lymphocyte ratio may predict benefit from Cisplatin in the advanced biliary cancer: The ABC-02 and BT-22 studies.
Affiliation
UCL Cancer Institute, UCL, London, UKIssue Date
2015-06-02
Metadata
Show full item recordAbstract
The superiority of cisplatin and gemcitabine (CisGem) chemotherapy over gemcitabine (Gem) alone in patients with advanced biliary tract cancer (ABC) has been demonstrated in two randomised trials; ABC02 and the Biliary Tract (BT) 22 study. We used a combined dataset from these two trials to investigate the derived neutrophil to lymphocyte ratio (dNLR), which is thought to be a prognostic factor associated with clinical outcomes in several solid tumours, including ABC.Citation
Derived neutrophil lymphocyte ratio may predict benefit from Cisplatin in the advanced biliary cancer: The ABC-02 and BT-22 studies. 2015: Ann OncolJournal
Annals of OncologyDOI
10.1093/annonc/mdv253PubMed ID
26037798Type
ArticleLanguage
enISSN
1569-8041ae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdv253
Scopus Count
Collections
Related articles
- Advanced Biliary Tract Cancer Treated with Gemcitabine plus Cisplatin (GEMCIS) and Novel Inflammatory Markers.
- Authors: Ogul A, Kidi MM, Buyuksimsek M
- Issue date: 2021 Mar
- Cisplatin and gemcitabine in patients with advanced biliary tract cancer (ABC) and persistent jaundice despite optimal stenting: Effective intervention in patients with luminal disease.
- Authors: Lamarca A, Benafif S, Ross P, Bridgewater J, Valle JW
- Issue date: 2015 Sep
- The Effect of Inflammatory Markers on Survival in Advanced Biliary Tract Carcinoma Treated with Gemcitabine/Oxaliplatin Regimen.
- Authors: Buyuksimsek M, Kidi MM, Ogul A, Mirili C, Paydas S
- Issue date: 2021 Mar
- Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials.
- Authors: Valle JW, Furuse J, Jitlal M, Beare S, Mizuno N, Wasan H, Bridgewater J, Okusaka T
- Issue date: 2014 Feb
- Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study.
- Authors: Rimini M, Masi G, Lonardi S, Nichetti F, Pressiani T, Lavacchi D, Jessica L, Giordano G, Scartozzi M, Tamburini E, Pastorino A, Rapposelli IG, Daniele B, Martinelli E, Garajova I, Aprile G, Schirripa M, Formica V, Salani F, Winchler C, Bergamo F, Balsano R, Gusmaroli E, Lorenzo A, Landriscina M, Pretta A, Toma I, Pirrone C, Diana A, Leone F, Brunetti O, Brandi G, Garattini SK, Satolli MA, Rossari F, Fornaro L, Niger M, Zanuso V, De Rosa A, Ratti F, Aldrighetti L, De Braud F, Foti S, Rizzato MD, Vivaldi C, Stefano C, Rimassa L, Antonuzzo L, Casadei-Gardini A
- Issue date: 2024 May